Citadel Advisors
TPST icon

Citadel Advisors’s Tempest Therapeutics TPST Stock Holding History

Citadel Advisors’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,095
Closed -$145K – 15268
2024
Q2 		$202K Buy
+7,095
New +$307K ﹤0.01% 9920
2024
Q1 		– Hold
0
– – – 14462
2023
Q4 		– Sell
-3,452
Closed -$163K – 15270
2023
Q3 		$14K Buy
+3,452
New +$33.1K ﹤0.01% 12897
2021
Q2 		– Sell
-2,054
Closed -$480K – 14447
2021
Q1 		$480K Sell
2,054
-2,135
-51% -$863K ﹤0.01% 9763
2020
Q4 		$1.75M Buy
4,189
+119
+3% +$41.1K ﹤0.01% 5637
2020
Q3 		$1.29M Buy
4,070
+810
+25% +$275K ﹤0.01% 5560
2020
Q2 		$1.12M Buy
3,260
+1,339
+70% +$534K ﹤0.01% 5627
2020
Q1 		$1.98M Buy
+1,921
New +$2.8M ﹤0.01% 4163
2018
Q2 		– Sell
-14
Closed -$33K – 9295
2018
Q1 		$33K Buy
+14
New +$42K ﹤0.01% 8031
2017
Q4 		– Sell
-20
Closed -$83K – 8444
2017
Q3 		$83K Buy
20
+16
+400% +$68.4K ﹤0.01% 7086
2017
Q2 		$17K Hold
4
– – ﹤0.01% 7319
2017
Q1 		$22K Hold
4
– – ﹤0.01% 7230
2016
Q4 		$16K Buy
+4
New +$49.8K ﹤0.01% 7125
2016
Q3 		– Sell
-8
Closed -$122K – 7778
2016
Q2 		$122K Buy
+8
New +$183K ﹤0.01% 6108
2015
Q4 		– Sell
-17
Closed -$413K – 9204
2015
Q3 		$413K Sell
17
-89
-84% -$5.99M ﹤0.01% 5069
2015
Q2 		$9.01M Buy
106
+8
+8% +$733K 0.01% 1543
2015
Q1 		$9.95M Buy
+98
New +$13.1M 0.01% 1456

Other funds holding TPST

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's TPST Position: Q3 2024 in Review

Citadel Advisors sold out of Tempest Therapeutics (TPST) in Q3 2024, closing a stake of 7,095 shares — an estimated $145K sold.

Citadel Advisors first reported a position in TPST in Q1 2015 and held it in 16 quarters. The position peaked at $9.95M in Q1 2015. 28 funds tracked by Wall St. Rank hold TPST as of Q3 2024.

  • Citadel Advisors reported no remaining Tempest Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 7,095 Tempest Therapeutics shares in Q3 2024, an estimated $145K.
  • Citadel Advisors first reported a position in Tempest Therapeutics in Q1 2015 and held it in 16 quarters.
  • Citadel Advisors's Tempest Therapeutics position peaked at $9.95M in Q1 2015.
  • 28 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.